An interventional study of Dietary Supplement in Xerostomia, sponsored by Lacer S.A.. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Lacer S.A. (part of Italfarmaco) · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies in Xerostomia with a site in Spain — 4 open to participants now, 6 under way, none of them phase 3. Xerostomia · Spain.
Among the 19 studies in Xerostomia with a site in Spain, this one is the 14th largest by planned enrollment of the 18 interventional ones that give a count, is one of 2 that started in 2026, is one of 12 with no phase, and was the 19th registered.
286 studies on the registry are indexed under Xerostomia; 50 are open to participants now.
Browse Xerostomia studies →4 of the 19 studies in Xerostomia with a site in Spain are open now. Recruiting first, the newest first:
University of Barcelona · Sites in Spain
Ages 18+
Universidad de Granada · Sites in Spain
Ages 18+
University of Santiago de Compostela · Sites in Spain
Ages 18+ · Healthy volunteers
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 26 Xerostomia studies recruiting now, 15 (58%) set no upper age limit and 7 (27%) stop at 75 or younger; 2 take children under 18; 5 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 5 · Phase 3 1
First in 2011; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 35 is below the median of 42 across 235 interventional studies indexed under Xerostomia.
Median enrollment 47 across the 18 interventional studies, 30 across the 1 observational. Of the 11 that completed or were terminated, 3 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 19 have an industry lead sponsor. The 10 most frequent:
This study is registered under Lacer S.A., one of the names counted as Italfarmaco. Under that name alone:
Lacer S.A. is the lead sponsor of 13 studies on the registry; 5 are open to participants now.
Italfarmaco has 1 study filed under Xerostomia — fewer than ten, so there is no comparison to draw.
3 of the studies in Xerostomia with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07594184University of BarcelonaDoes Hyaluronic Acid Help Relieve Dry Mouth? | 2026-11 |
| NCT07847840Lacer S.A.Effect of the Dietary Supplement to Alleviate Dry Mouth. | 2026-12 |
| NCT06928142Otsuka Pharmaceutical Development & Commercialization, Inc.A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's | 2027-03-13 |
Add all 3 to your calendar (.ics) → With an account.
Among the 19 studies in Xerostomia with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this study is to learn if dietary supplement works to improve dry mouth in adults. The main question it aims to answer is:
Participants will:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Dietary supplement will be taken daily for 7 days
Dietary Supplement: Dietary Supplement
Dietary supplement will be taken daily for 7 days
Change from Baseline in the dry mouth intensity at 7 days
The dry mouth sensation will be evaluated by numeric dryness scale from 0 (no dryness) to 10 (maximum dryness imaginable).
Time frame: From enrollment to the end of the study at 7 days
Plan to share: No — Only data included in the publication will be shared.
No publications or documents are linked to this record.
Started Oct 2026 (actual). Primary completion is estimated for Dec 2026, 2 months after the start.
Of 103 interventional studies with no phase under Xerostomia, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 31. This study's planned 2 months is below that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.